SciELO - Scientific Electronic Library Online

 
vol.25 issue1INFLUENCE OF TEACHERS’ DIGITAL COMPETENCE ON THE ACHIEVEMENT OF ICT COMPETENCE IN SECONDARY EDUCATION STUDENTSCOAGULATION-FLOCCULATION AS A POLISHING STRATEGY FOR SECONDARY EFFLUENTS IN MUNICIPAL WASTEWATER TREATMENT PLANTS author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Investigación & Desarrollo

On-line version ISSN 2518-4431

Abstract

OCAMPO VALDIVIA, Mayra Fernanda  and  CUIZA FLORES, Sergio Andrés. BACTERIOTHERAPY IN ONCOLOGY: ADVANCES IN THE USE OF MICROORGANISMS TO OPTIMIZE THE ANTITUMOR IMMUNE RESPONSE. Inv. y Des. [online]. 2025, vol.25, n.1, pp.29-41.  Epub July 30, 2025. ISSN 2518-4431.  https://doi.org/10.23881/idupbo.025.1-3i.

Cancer represents a significant global challenge due to its biological complexity, tumor heterogeneity, and the limitations of conventional therapies such as chemotherapy, radiotherapy, and certain immunotherapies, which often exhibit low specificity and considerable side effects. In this context, oncological bacteriotherapy has emerged as an innovative alternative within the field of immunotherapy, utilizing genetically modified bacteria to specifically target the tumor microenvironment. This review focused on analyzing the therapeutic potential of five bacterial species: Clostridium novyi-NT, Salmonella enterica serovar Typhimurium, Listeria monocytogenes, Escherichia coli, and Bifidobacterium longum, their mechanisms of action, efficacy, advantages, limitations, progress in preclinical and clinical studies, and their potential use in combination with other therapies. Additionally, an analysis of empirical data reported up to 2020 was conducted, identifying positive trends in success rates. Based on this, estimated projections for the 2025-2030 period was developed, outlining an optimistic yet realistic scenario that considers plausible clinical and statistical criteria to envision a future in which modified bacteria could become effective, customizable, and safe therapeutic tools. This study proposes and scientifically supports the value of bacteriotherapy as an emerging avenue for cancer treatment. By demonstrating tumor specificity, genetic engineering capabilities, and a low immunogenic profile, this work seeks to promote its development and clinical application.

Keywords : Bacteriotherapy; Immunotherapy; Cancer; Genetically Modified Bacteria; Oncological Treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )